On Tuesday, Shares of Gramercy Property Trust (NYSE:GPT), subtract -0.68% and closed at $8.78 in the last trading session. The last trading range of the stock ranges between $8.72 and $9.00. The company’s Market capitalization is $3.72 Billion with the total Outstanding Shares of 421.86 million. During the 52-week trading session the minimum price at which share price traded, registered at $6.34 and reached to max level of $10.03. Gramercy Property Trust (GPT) declared recently that it will release earnings for the third quarter 2016 on Wednesday, November 2, 2016, before market open.
The Company’s executive administration team will host a conference call and audio webcast on Wednesday, November 2, 2016, at 11:00 AM EDT to discuss third quarter 2016 financial results. Presentation materials will be posted before the call on the Company’s website.
Endo International plc – Ordinary Shares (NASDAQ:ENDP), dropped -3.40% and closed at $20.46 in the last trading session. The last trading range of the stock ranges between $20.27 and $21.29. During the 52-week trading session the minimum price at which share price traded, registered at $12.56 and reached to max level of $69.33. Endo Pharmaceuticals Inc., a partner of Endo International plc (ENDP) (ENL.TO), recently declared new data to be presented evaluating the safety and efficacy of XIAFLEX®(collagenase clostridium histolyticum) (or CCH) injection under investigation for the treatment of palmar Dupuytren’s disease nodules. The findings will be presented during a podium presentation on Saturday, October 1, 2016 at 10:40 a.m. CDT at the annual meeting of the American Society for Surgery of the Hand (ASSH) held from September 29 to October 1, 2016 in Austin, Texas.
In a Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study, in 75 adult study participants with Dupuytren’s disease and at least 1 nodule who received a single injection of CCH 0.40 mg or 0.60 mg, a statistically noteworthydecrease was shown from baseline in the mean nodule surface area (P≤0.001), consistency score (P<0.001) and hardness score (P≤0.01) at week 8 as compared to study participants receiving placebo. The safety profile of those treated with CCH was generally well tolerated. Adverse events included extremity pain, axillary pain, injection site-related adverse events and pruritus. One adverse event was stated as severe (injection site pain with CCH 0.60 mg). No patients were suspended from the study because of an adverse event.
On the otherhand Illinois Tool Works Inc. (NYSE:ITW), lost -1.18% and closed at $115.04 in the last trading session. The last trading range of the stock ranges between $113.82 and $116.41. The company’s Market capitalization is $40.56 billion with the total Outstanding Shares of 354.96 million. During the 52-week trading session the minimum price at which share price traded, registered at $79.15 and reached to max level of $123.50. Illinois Tool Works Inc. manufactures and sells industrial products and equipment worldwide. It operates through seven segments: Automotive OEM; Test & Measurement and Electronics; Food Equipment; Polymers & Fluids; Welding; Construction Products; and Specialty Products. The Automotive OEM segment produces components and fasteners for automotive-related applications. The Test & Measurement and Electronics segment provides equipment, consumables, and related software for testing and measuring of materials and structures, in addition to equipment and consumables used in the production of electronic subassemblies and microelectronics. The Food Equipment segment offers commercial food equipment and related services. The Polymers & Fluids segment produces adhesives, sealants, lubrication and cutting fluids, and fluids and polymers for auto aftermarket maintenance and appearance. The Welding segment produces arc welding equipment, consumables, and accessories for various industrial and commercial applications. The Construction Products segment produces engineered fastening systems and solutions. The Specialty Products segment provides beverage packaging equipment and consumables, product coding and marking equipment and consumables, and appliance components and fasteners.